New Frontier Health Corporation Stock price

NFH

KYG6461G1064

Healthcare Facilities & Services

Delayed Nyse Other stock markets 04:10:00 2022-01-26 pm EST			5-day change	1st Jan Change
11.95 ^USD	+0.25%		+3.91%	+4.28%

2022	New Frontier Health Corporation(NYSE:NFH) dropped from S&P Global BMI Index	CI
2022	A group of buyers completed the acquisition of remaining stake in New Frontier Health Corporation from its shareholders.	CI

Chart New Frontier Health Corporation

Duration

Period

Style

Dynamic Chart

Latest news about New Frontier Health Corporation

New Frontier Health Corporation(NYSE:NFH) dropped from S&P Global BMI Index	2022	CI
A group of buyers completed the acquisition of remaining stake in New Frontier Health Corporation from its shareholders.	2022	CI
Broncus to Invest $3 Million in Member of Consortium for New Frontier Health's Go-Private Deal	2021	MT
Broncus Enter into Strategic Partnership with New Frontier Health Corporation /United Family Healthcare	2021	CI
New Frontier Health Schedules Jan. 4 Shareholder Vote on Going-Private Transaction; Stock Rising in After-Hours Trade	2021	MT
New Frontier Health Corporation(NYSE:NFH) added to S&P Global BMI Index	2021	CI
Shanghai Fosun Pharmaceutical : Fosun Pharma Joins Buyer Consortium for $1.6 Billion Privatization of New Frontier Health	2021	MT
New Frontier Health : to Go Private via Merger With Unicorn II Holdings	2021	MT
NEW FRONTIER HEALTH : Credit Suisse Downgrades New Frontier Health to Neutral Rating From Outperform, Price Target is $12	2021	MT
Transcript : New Frontier Health Corporation, Q4 2020 Earnings Call, Apr 08, 2021	2021	CI
New Frontier Health Corporation Announces Formation of Special Committee	2021	CI
New Frontier Health : Receives 'Going-Private' Proposal; Shares Rise	2021	MT
A group of buyers entered into a non binding proposal letter to acquire the remaining stake in New Frontier Health Corporation from its shareholders for approximately of $940 million.	2021	CI
Transcript : New Frontier Health Corporation, Q3 2020 Earnings Call, Dec 02, 2020	2020	CI
New Frontier Health : Fiscal Q3 Loss Narrows Year/Year Amid Revenue Growth; Q4 Revenue Seen Flat to Up Slightly	2020	MT

More news

Analyst Recommendations on New Frontier Health Corporation

NEW FRONTIER HEALTH : Credit Suisse Downgrades New Frontier Health to Neutral Rating From Outperform, Price Target is $12

2021

More recommendations

Press releases New Frontier Health Corporation

New Frontier Health : Announces Completion of Going Private Transaction - Form 6-K	2022	PU
New Frontier Health Corporation Announces Completion of Going Private Transaction	2022	BU
New Frontier Health : Receives Notification from NYSE Regarding Delayed Filing of Semi-Annual Financial Information for the Half Year Ended June 30, 2021 - Form 6-K	2022	PU
New Frontier Health Corporation Receives Notification from NYSE Regarding Delayed Filing of Semi-Annual Financial Information for the Half Year Ended June 30, 2021	2022	BU
New Frontier Health : Announces Shareholders’ Approval of Merger Agreement and Warrantholders’ Approval of Warrant Amendment - Form 6-K	2022	PU

More press releases

Managers and Directors - New Frontier Health Corporation

Managers	Title	Age	Since
Carl Wu CEO	Chief Executive Officer	39	2018
Walter Xue DFI	Director of Finance/CFO	55	2018
Pu Yan Mah CTO	Chief Tech/Sci/R&D Officer	43	2021

Members of the board	Title	Age	Since
Kam Chung Leung FOU	Founder	71	2018
Qi Yu Chen CHM	Chairman	51	2019
Shan Fu BRD	Director/Board Member	55	2019

More insiders

New Frontier Health Corporation is a company principally engaged in the provision of healthcare services. The Company operates private hospitals, outpatient clinics and medical centers. The Company provides preventive care, diagnosis, treatment and rehabilitation services, among others.

Sector

Healthcare Facilities & Services

More about the company

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
NEW FRONTIER HEALTH CORPORATION	+4.28%	1 576 M $
CVS HEALTH CORPORATION	-19.41%	96 646 M $
HCA HEALTHCARE, INC.	+7.32%	68 931 M $
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+27.74%	26 296 M $
LABORATORY CORPORATION OF AMERICA HOLDINGS	-8.02%	18 389 M $
QUEST DIAGNOSTICS INCORPORATED	-13.12%	15 281 M $
REDE D'OR SÃO LUIZ S.A.	-10.41%	12 125 M $
FRESENIUS MEDICAL CARE AG	+24.80%	12 035 M $
EUROFINS SCIENTIFIC SE	-17.98%	11 404 M $
DAVITA INC.	+44.07%	9 827 M $